Manuela Hoffmann-Lücke

Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden.

Part of Baxter International, Inc., Baxter Deutschland Holding GmbH is an investment holding German company. The company is based in Unterschleißheim, Germany. The CEOs are Kirstin Fischer and Philipp Saame. The company was founded in 1999.

Part of Baxter International, Inc., Baxter Deutschland GmbH is a German company that changes the lives of millions of people around the world every day. The company is based in Unterschleißheim, Germany. Baxter's products and therapies are used in hospitals and clinics, from the emergency room to the operating room, from the pharmacy to the intensive care unit, improving the care of patients at home. The company's focus on corporate governance is crucial in today's business environment, where investor and public confidence in the company is no longer based solely on financial performance or products and services. Baxter helps maximize safety, streamline procedures, and establish cost efficiencies throughout the clinic. The company was founded in 1960, and the CEO is Christian Wrabetz.